Virtu Financial LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 101 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$37
-64.1%
12,208
-72.4%
0.00%
-71.4%
Q4 2022$103
-99.9%
44,194
-16.2%
0.01%
+16.7%
Q2 2022$143,000
-49.3%
52,722
-43.4%
0.01%
-55.6%
Q2 2021$282,000
+32.4%
93,196
+45.8%
0.03%
+80.0%
Q1 2021$213,000
-4.1%
63,941
+2.3%
0.02%
-37.5%
Q4 2020$222,000
+616.1%
62,530
+264.7%
0.02%
+500.0%
Q2 2020$31,000
-39.2%
17,147
-30.1%
0.00%
+33.3%
Q2 2019$51,000
-10.5%
24,548
+117.5%
0.00%0.0%
Q4 2017$57,00011,2870.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2021
NameSharesValueWeighting ↓
COWEN AND COMPANY, LLC 4,331,020$7,882,0001.31%
RTW INVESTMENTS, LP 6,869,281$12,502,0000.35%
A.R.T. Advisors, LLC 14,140$26,0000.04%
Hudson Bay Capital Management LP 975,000$1,774,0000.03%
Secure Asset Management, LLC 10,000$18,0000.01%
OSAIC HOLDINGS, INC. 1,774,935$3,230,0000.01%
FNY Investment Advisers, LLC 9,900$18,0000.01%
Squarepoint Ops LLC 322,225$586,0000.01%
LMR Partners LLP 107,912$196,0000.01%
Virtu Financial LLC 17,147$31,0000.00%
View complete list of ARBUTUS BIOPHARMA CORP shareholders